Apollon Wealth Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-3,555
Closed -$256K – 804
2022
Q1
$256K Sell
3,555
-125
-3% -$9.01K 0.02% 624
2021
Q4
$338K Buy
3,680
+2,074
+129% +$248K 0.03% 556
2021
Q3
$204K Buy
1,606
+232
+17% +$33.8K 0.03% 436
2021
Q2
$228K Sell
1,374
-33
-2% -$5.35K 0.04% 332
2021
Q1
$256K Buy
1,407
+275
+24% +$63.8K 0.05% 294
2020
Q4
$226K Buy
+1,132
New +$230K 0.06% 173
2020
Q3
– Sell
-451
Closed -$86K – 629
2020
Q2
$86K Buy
+451
New +$79K 0.05% 187

Other funds holding TDOC

Apollon Wealth Management's TDOC Position: Q2 2022 in Review

Apollon Wealth Management sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 3,555 shares — an estimated $256K sold.

Apollon Wealth Management first reported a position in TDOC in Q2 2020 and held it in 7 quarters. The position peaked at $338K in Q4 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Apollon Wealth Management reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Apollon Wealth Management sold 3,555 Teladoc Health shares in Q2 2022, an estimated $256K.
  • Apollon Wealth Management first reported a position in Teladoc Health in Q2 2020 and held it in 7 quarters.
  • Apollon Wealth Management's Teladoc Health position peaked at $338K in Q4 2021.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Apollon Wealth Management's 13F filing for Q2 2022, filed 11 Aug 2022.